Cart
sales@molnova.com
IM176OUT05
CAS No. 1544871-16-0
IM176OUT05( IM176 OUT05 | IM176OUT05, IM )
Catalog No. M27989 CAS No. 1544871-16-0
IM176OUT05 activates stem cell metabolism with hair regrowth-promoting effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 896 | Get Quote |
|
| 100MG | 1413 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIM176OUT05
-
NoteResearch use only, not for human use.
-
Brief DescriptionIM176OUT05 activates stem cell metabolism with hair regrowth-promoting effects.
-
DescriptionIM176OUT05 activates stem cell metabolism with hair regrowth-promoting effects.
-
In Vitro——
-
In Vivo——
-
SynonymsIM176 OUT05 | IM176OUT05, IM
-
PathwayOthers
-
TargetOther Targets
-
RecptorTLR7|TLR8|Reactive Oxygen Species
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1544871-16-0
-
Formula Weight255.75
-
Molecular FormulaC11H18ClN5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cc1ccccc1CCNC(=N)NC(N)=N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Karama Makni-Maalej, et al. The TLR7/8 agonist CL097 primes N-formyl-methionyl-leucyl-phenylalanine-stimulated NADPH oxidase activation in human neutrophils: critical role of p47phox phosphorylation and the proline isomerase Pin1. J Immunol. 2012 Nov 1;189(9):4657-65.
molnova catalog
related products
-
(z)-4,6-Dihydroxy-2-...
4,6,4'-Trihydroxy-3'-methoxyaurone is an herbicide. At concentrations of 100 and 1000 μg/mL, 4,6,4'-Trihydroxy-3'-methoxyaurone is able to inhibit the growth of rape root and barnyardgrass seedlings1.
-
CGRP II, rat (TFA) (...
Calcitonin Gene Related Peptide (CGRP) II, rat (TFA) is a neuropeptide with 37 amino acid.
-
Simlukafusp alfa
Simlukafusp alfa (FAP-IL2v) is a tumor-targeting immune cytokine, a human IgG1 antibody, with antitumor activity and immunostimulatory properties that potentiate in vitro and in vivo activity of therapeutic antibodies mediating antibody-dependent or T-cell-independent cytotoxicity (TDCC) and programmed death ligand 1 (PD-L1) checkpoint inhibition.
